CFP home page - Quick Quizzes

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

ACOG 2025: Elizabeth Mollard, PhD, discusses her research on how Medicaid policies influence postpartum depression screening rates.

May 7th 2025

Real-World Memory Clinic Data Suggest Lecanemab Use Is Feasible, Practical for Adults with Alzheimer Disease

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

New Real-World Data Suggest Lecanemab Use Is Feasible, Practical, with Manageable Adverse Events / image credit WashU Medicine Dept of Neurology

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Adults with early AD who were treated with lecanemab in a specialty memory clinic experienced adverse events comparable to those seen in clinical trials.

Linda Stein Gold, MD;Sydney Jennings

March 9th 2025

FDA Grants Novavax COVID-19 Vaccine Full Approval for High-Risk Groups

“I think it’s important to have a lot of tools in our toolbox, and [tapinarof cream 1%] is one that gives us great flexibility," said Linda Stein Gold, MD.

Study Shows Sharp Rise in GI Cancers Among Young Adults: Daily Dose

Nuvaxovid (NVX-CoV2373) is indicated for those aged ≥65 years and aged 12 to 64 years with at least one condition that puts them at high risk for severe infection.

May 19th 2025

PPD Screening, Medicaid Coverage, and Access to Care: A Q&A with Elizabeth Mollard, PhD

Your daily dose of the clinical news you may have missed.

Related Content

Elizabeth Mollard, PhD;Sydney Jennings

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

ACOG 2025: Elizabeth Mollard, PhD, discusses her research on how Medicaid policies influence postpartum depression screening rates.

May 7th 2025

Real-World Memory Clinic Data Suggest Lecanemab Use Is Feasible, Practical for Adults with Alzheimer Disease

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Adults with early AD who were treated with lecanemab in a specialty memory clinic experienced adverse events comparable to those seen in clinical trials.

Linda Stein Gold, MD;Sydney Jennings

March 9th 2025

FDA Grants Novavax COVID-19 Vaccine Full Approval for High-Risk Groups

“I think it’s important to have a lot of tools in our toolbox, and [tapinarof cream 1%] is one that gives us great flexibility," said Linda Stein Gold, MD.

Study Shows Sharp Rise in GI Cancers Among Young Adults: Daily Dose

Nuvaxovid (NVX-CoV2373) is indicated for those aged ≥65 years and aged 12 to 64 years with at least one condition that puts them at high risk for severe infection.

May 19th 2025